Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: prospective single‐center study

I Sakellari, E Gavriilaki, I Batsis… - Journal of Clinical …, 2018 - Wiley Online Library
Background Graft vs host disease (GVHD) is the most severe complication of allogeneic
hematopoietic cell transplantation. Conventional immunosuppressive therapy increases …
被引用次数：35 相关文章

Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single‐center study.

I Sakellari, E Gavriilaki, I Batsis… - Journal of Clinical …, 2018 - search.ebscohost.com
Background: Graft vs host disease (GVHD) is the most severe complication of allogeneic
hematopoietic cell transplantation. Conventional immunosuppressive therapy increases …

Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single-center study

I Sakellari, E Gavriilaki, I Batsis… - Journal of clinical …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Graft vs host disease (GVHD) is the most severe complication of allogeneic
hematopoietic cell transplantation. Conventional immunosuppressive therapy increases …

Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single‐center study

I Sakellari, E Gavriilaki, I Batsis, D Mallouri… - Journal of Clinical …, 2018 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
Graft vs host disease (GVHD) is the most severe complication of allogeneic hematopoietic …

Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single-center study.

I Sakellari, E Gavriilaki, I Batsis, D Mallouri… - Journal of Clinical …, 2018 - europepmc.org
Background Graft vs host disease (GVHD) is the most severe complication of allogeneic
hematopoietic cell transplantation. Conventional immunosuppressive therapy increases …